Weight-loss surgery to protect fertility in early womb cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether bariatric (weight-loss) surgery can help treat certain early, low-grade womb changes while preserving fertility. It’s mainly for people with a higher BMI who want to have children and have an early stage diagnosis confirmed by scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- BMI is 35 or higher
- You have been diagnosed with either grade 1 endometrial cancer or complex atypical hyperplasia
- Your scans show it is confined to the uterus (stage 1) with no spread
- You want fertility preservation (future pregnancy)
- You must be able to safely get a progestin IUD and also safely have a sleeve gastrectomy
- You are not pregnant and you can fully understand and consent to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a three-month program that includes weight-loss medications and hormone therapy before surgery is better than surgery alone for women with early-stage endometrial cancer and severe obesity. The goal is to see if this approach improves surgical outcomes and overall health.
This trial tests whether an app-based weight management program can help people with endometrial cancer who want to preserve their fertility. It's for those with a BMI of 25 or higher and early-stage, low-grade cancer that hasn't spread.
This study tests a new weight-loss procedure called Endoscopic Suture Gastroplasty (ESG) for women with endometrial (uterine) cancer who are obese. The procedure uses a special camera and stitches to make the stomach smaller, helping you lose weight before your cancer surgery.
This trial compares robotic-assisted surgery versus standard laparoscopic surgery for people with early-stage uterine (endometrial) cancer and a BMI of 30 or higher. The goal is to see which approach is safer and works better for this group.
This trial studies whether a higher-protein, lower-calorie diet before sleeve gastrectomy (a type of weight-loss surgery) changes outcomes after surgery. You may be able to join if you’re scheduled for the operation and meet specific health and safety requirements.
This study tests whether a weight-loss medication (tirzepatide) can help shrink early-stage, low-grade endometrial cancer or atypical hyperplasia while you keep your uterus for future pregnancy. It is designed for women who are overweight and wish to preserve their fertility.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.